Transfusion Technologies Corp.
This article was originally published in The Gray Sheet
Executive Summary
Haemonetics' $15 mil. investment in the privately-held blood processing equipment maker adds up to a 19.8% ownership stake. Under the terms of a strategic relationship announced Nov. 8, Haemonetics will become the exclusive European and Asian distributor for Transfusion's OrthoPAT autotransfusion system for use in blood salvaging during orthopedic surgery. The funding will allow Transfusion "to develop and bring to market other new blood processing systems based on our patented Dynamic Disk technology," the firm says